These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2636666)

  • 1. Metabolic effects of supplementation of L-carnitine in the dialysate of patients treated with acetate hemodialysis.
    Guarnieri G; Toigo G; Crapesi L; Situlin R; Del Bianco MA; Corsi M; Lo Greco P; Vasile A
    Kidney Int Suppl; 1989 Nov; 27():S247-55. PubMed ID: 2636666
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of dialysate composition on the lipid response to L-carnitine supplementation.
    Zilleruelo G; Novak M; Hsia SL; Goldberg R; Abitbol C; Monkus E; Strauss J
    Kidney Int Suppl; 1989 Nov; 27():S259-63. PubMed ID: 2699997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ketogenic and antiketogenic effects of L-carnitine in hemodialysis patients.
    Wanner C; Wieland H; Wäckerle B; Boeckle H; Schollmeyer P; Hörl WH
    Kidney Int Suppl; 1989 Nov; 27():S264-8. PubMed ID: 2636668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carnitine metabolism in chronic renal failure. Acute effects of carnitine addition to the dialysate during acetate hemodialysis.
    Guarnieri G; Toigo G; Crapesi L; Situlin R; Del Bianco MA; Corsi M; Lo Greco P; Vasile A
    Contrib Nephrol; 1988; 65():1-23. PubMed ID: 3048873
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of low dose supplementation of L-carnitine on lipid metabolism in hemodialyzed children.
    Glöggler A; Bulla M; Fürst P
    Kidney Int Suppl; 1989 Nov; 27():S256-8. PubMed ID: 2636667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carnitine metabolism in patients with chronic renal failure: effect of L-carnitine supplementation.
    Wanner C; Förstner-Wanner S; Rössle C; Fürst P; Schollmeyer P; Hörl WH
    Kidney Int Suppl; 1987 Oct; 22():S132-5. PubMed ID: 3480977
    [No Abstract]   [Full Text] [Related]  

  • 7. [Acetate-free on-line PHF: how to improve hyperacetatemia and haemodynamic tolerance].
    Coll E; Pérez-García R; Martín de Francisco AL; Galcerán J; García-Osuna R; Martín-Malo A; Martínez-Castelao A; Sánchez B; Llopis R; Alvarez de Lara MA
    Nefrologia; 2009; 29(2):156-62. PubMed ID: 19396322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical and analytical changes in hemodialysis without acetate].
    Coll E; Pérez-García R; Rodríguez-Benítez P; Ortega M; Martínez Miguel P; Jofré R; López-Gómez JM
    Nefrologia; 2007; 27(6):742-8. PubMed ID: 18336105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocrine-metabolic effects of l-carnitine in patients on regular dialysis treatment.
    Albertazzi A; Capelli P; Di Paolo B; Pola P; Tondi P; Vaccario O
    Proc Eur Dial Transplant Assoc; 1983; 19():302-7. PubMed ID: 6878245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carnitine nutriture of dialysis patients.
    Borum PR; Taggart EM
    J Am Diet Assoc; 1986 May; 86(5):644-7. PubMed ID: 3700927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. L-carnitine in dialysed patients: the choice of dosage regimen.
    Berard E; Iordache A; Barrillon D; Bayle J
    Int J Clin Pharmacol Res; 1995; 15(3):127-33. PubMed ID: 8847154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. L-carnitine and acetyl-L-carnitine status during hemodialysis with acetate in humans: a kinetic analysis.
    Jackson JM; Lee HA
    Am J Clin Nutr; 1996 Dec; 64(6):922-7. PubMed ID: 8942418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Secondary L-carnitine deficiency in chronic hemodialysis patients].
    Achenbach H; Würzberger G; Seim H; Löster H; Strauss B
    Z Gesamte Inn Med; 1989 Jan; 44(1):18-22. PubMed ID: 2711712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What is the value of L-carnitine level determination for carnitine supplementation in hemodialysis patients?
    Reuter SE; Evans AM
    Hemodial Int; 2013 Jul; 17(3):335-8. PubMed ID: 23360342
    [No Abstract]   [Full Text] [Related]  

  • 15. L-carnitine: its therapeutic potential.
    DiPalma JR
    Am Fam Physician; 1986 Dec; 34(6):127-30. PubMed ID: 3788753
    [No Abstract]   [Full Text] [Related]  

  • 16. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates.
    Elsharkawy MM; Youssef AM; Zayoon MY
    Hemodial Int; 2006 Oct; 10 Suppl 2():S16-23. PubMed ID: 17022745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypersensitivity reactions during hemodialysis related to the use of acetate dialysate. A case report.
    Papadakis JT; Patrikarea A; Saradi S; Papakostas K; Leondi A; Kravaritis A; Vafiadis S
    Clin Nephrol; 1991 May; 35(5):224-6. PubMed ID: 1855330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. L-carnitine addition to dialysis fluid. A therapeutic alternative for hemodialysis patients.
    Vacha GM; Giorcelli G; d'Iddio S; Valentini G; Bagiella E; Procopio A; di Donato S; Ashbrook D; Corsi M
    Nephron; 1989; 51(2):237-42. PubMed ID: 2915763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. L-carnitine use in dialysis patients: is national coverage for supplementation justified? What were CMS regulators thinking--or were they?
    Steinman TI; Nissenson AR; Glassock RJ; Dickmeyer J; Mattern WD; Parker TF; Hull AR
    Nephrol News Issues; 2003 Apr; 17(5):28-30, 32-4, 36 passim. PubMed ID: 12715624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Excessive ATP degradation during hemodialysis against sodium acetate.
    Tekkanat KK; Port FK; Schmaltz S; Chen T; Fox IH
    J Lab Clin Med; 1988 Dec; 112(6):686-93. PubMed ID: 3193024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.